Search
Close this search box.

LUV IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Southwest Airlines Co. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – LUV

NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Southwest Airlines Co. (NYSE: LUV) between June 13, 2020 and December 31, 2022, both dates inclusive (the “Class Period”), of the important March 13, 2023 lead plaintiff deadline in the securities class action commenced by […]

Continue Reading ➜

NRIA DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages National Realty Investment Advisors LLC Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action – NRIA

NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of National Realty Investment Advisors LLC membership units (NRIA) of the important March 13, 2023 lead plaintiff deadline in the securities class action. The case is against Rey E. Grabato II, Daniel Coley O’Brien, Thomas Nicholas Salzano, Arthur Scutaro, […]

Continue Reading ➜

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESS Tech Inc. Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action Filed by the Firm – GWH

NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ESS Tech Inc. (NYSE: GWH) between August 11, 2022 and December 7, 2022, both dates inclusive (the “Class Period”), of the important March 13, 2023 lead plaintiff deadline. SO WHAT: If you purchased ESS […]

Continue Reading ➜

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones All 115 patients implanted in DREAM U.S. pivotal study First DREAM PMA module submitted First patient implanted in ACCCESS U.S. pivotal study Mont-Saint-Guibert, Belgium – March 6, 2023, 7:30am CET / 1:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), […]

Continue Reading ➜

Recent News